Providing Regulatory Submissions in Electronic Format – Standardized Study Data

On 22 June 2021 the FDA published the final guidance for industry.

Under section 745A(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 379k-1(a)), at least 24 months after the issuance of a final guidance document in which the FDA has specified the electronic format for submitting certain submission types to the Agency, such content must be submitted electronically and in the format specified by FDA. This guidance and the technical specifications documents it incorporates by reference describe the requirements for an electronic submission of standardized clinical and nonclinical study data under section 745A(a) of the FD&C Act. In accordance with section 745A(a), following the issuance of a final guidance on this topic, study data contained in the submission types identified in this guidance must be submitted electronically in a format that FDA can process, review, and archive.

Read more online 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /